Zoetis Inc. $ZTS Shares Sold by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. decreased its position in shares of Zoetis Inc. (NYSE:ZTS) by 59.9% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 57,896 shares of the company’s stock after selling 86,357 shares during the period. Assenagon Asset Management S.A.’s holdings in Zoetis were worth $9,029,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the company. Nova Wealth Management Inc. acquired a new position in shares of Zoetis in the first quarter valued at approximately $25,000. 1248 Management LLC acquired a new position in shares of Zoetis in the first quarter worth $27,000. Saudi Central Bank acquired a new position in shares of Zoetis in the first quarter worth $29,000. Cornerstone Planning Group LLC increased its position in shares of Zoetis by 79.3% during the first quarter. Cornerstone Planning Group LLC now owns 199 shares of the company’s stock worth $30,000 after acquiring an additional 88 shares during the period. Finally, Migdal Insurance & Financial Holdings Ltd. raised its stake in shares of Zoetis by 87.6% in the first quarter. Migdal Insurance & Financial Holdings Ltd. now owns 257 shares of the company’s stock valued at $42,000 after acquiring an additional 120 shares in the last quarter. 92.80% of the stock is owned by institutional investors and hedge funds.

Zoetis Trading Down 1.5%

NYSE ZTS opened at $142.43 on Wednesday. The firm’s fifty day moving average is $150.82 and its two-hundred day moving average is $156.17. Zoetis Inc. has a one year low of $139.70 and a one year high of $197.51. The company has a debt-to-equity ratio of 1.05, a quick ratio of 1.04 and a current ratio of 1.76. The firm has a market cap of $63.12 billion, a PE ratio of 24.52, a P/E/G ratio of 2.32 and a beta of 0.89.

Zoetis (NYSE:ZTS) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $1.76 earnings per share for the quarter, beating analysts’ consensus estimates of $1.62 by $0.14. The firm had revenue of $2.46 billion for the quarter, compared to analyst estimates of $2.41 billion. Zoetis had a net margin of 27.83% and a return on equity of 56.90%. Zoetis’s quarterly revenue was up 4.2% on a year-over-year basis. During the same period last year, the firm posted $1.56 EPS. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. Analysts expect that Zoetis Inc. will post 6.07 earnings per share for the current year.

Analysts Set New Price Targets

Several brokerages have weighed in on ZTS. Leerink Partners downgraded Zoetis from an “outperform” rating to a “market perform” rating and cut their price target for the stock from $180.00 to $155.00 in a report on Thursday, July 17th. Piper Sandler upped their target price on shares of Zoetis from $210.00 to $215.00 and gave the stock an “overweight” rating in a research note on Monday, August 11th. Stifel Nicolaus downgraded shares of Zoetis from a “buy” rating to a “hold” rating and decreased their price target for the stock from $165.00 to $160.00 in a research note on Wednesday, June 18th. Argus reissued a “buy” rating and issued a $190.00 price objective on shares of Zoetis in a research report on Tuesday, September 9th. Finally, Leerink Partnrs cut shares of Zoetis from a “strong-buy” rating to a “hold” rating in a research report on Thursday, July 17th. Five analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $200.88.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.